Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Respiratory arrest at the onset of idiopathic childhood occipital epilepsy of Gastaut.

Funata K, Shike T, Takenouchi T, Yamashita Y, Takahashi T.

Brain Dev. 2018 Jan;40(1):74-76. doi: 10.1016/j.braindev.2017.06.009. Epub 2017 Jul 19.

PMID:
28734692
2.

A case of CDKL5 disorder: improved ADL by simple treatment strategy for intractable epileptic seizures.

Shike T, Takahashi Y, Kimura N, Imai K, Yamamoto T, Takahashi T.

No To Hattatsu. 2017 Jan;49(1):28-31. Japanese.

PMID:
30011151
3.

An infant with human parechovirus type 3 infection with a distinctive rash on the extremities.

Shoji K, Komuro H, Kobayashi Y, Shike T, Funaki T, Katsuta T, Miyata I, Saitoh A.

Pediatr Dermatol. 2014 Mar-Apr;31(2):258-9. doi: 10.1111/j.1525-1470.2012.01819.x. Epub 2012 Sep 3.

PMID:
22938181
4.

De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies.

Ogiwara I, Ito K, Sawaishi Y, Osaka H, Mazaki E, Inoue I, Montal M, Hashikawa T, Shike T, Fujiwara T, Inoue Y, Kaneda M, Yamakawa K.

Neurology. 2009 Sep 29;73(13):1046-53. doi: 10.1212/WNL.0b013e3181b9cebc.

5.

Pathogenesis and treatment of type 2 diabetic nephropathy: lessons from the spontaneous KK/Ta mouse model.

Tomino Y, Tanimoto M, Shike T, Shiina K, Fan Q, Liao J, Gohda T, Makita Y, Funabiki K.

Curr Diabetes Rev. 2005 Aug;1(3):281-6. Review.

PMID:
18220604
6.

Genetic susceptibility to type 2 diabetic nephropathy in human and animal models.

Gohda T, Tanimoto M, Watanabe-Yamada K, Matsumoto M, Kaneko S, Hagiwara S, Shiina K, Shike T, Funabiki K, Tomino Y.

Nephrology (Carlton). 2005 Oct;10 Suppl:S22-5. Review.

PMID:
16174283
7.

Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice.

Shike T, Gohda T, Tanimoto M, Kobayashi M, Makita Y, Funabiki K, Horikoshi S, Hirose S, Shirai T, Tomino Y.

Nephrol Dial Transplant. 2005 May;20(5):879-85. Epub 2005 Mar 15.

PMID:
15769825
8.

Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.

Tanimoto M, Fan Q, Gohda T, Shike T, Makita Y, Tomino Y.

Metabolism. 2004 Nov;53(11):1473-9.

PMID:
15536604
9.

Gene expression profile in diabetic KK/Ta mice.

Fan Q, Shike T, Shigihara T, Tanimoto M, Gohda T, Makita Y, Wang LN, Horikoshi S, Tomino Y.

Kidney Int. 2003 Dec;64(6):1978-85.

10.

Implication of the complement system in the induction of anti-glomerular basement membrane glomerulonephritis in WKY rats.

Shike T, Isome M, Mizuno M, Suzuki J, Matsuo S, Yamamoto T, Suzuki H.

Pathol Int. 2003 Nov;53(11):757-61.

PMID:
14629299
11.
12.
13.

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.

Tashiro K, Koyanagi I, Saitoh A, Shimizu A, Shike T, Ishiguro C, Koizumi M, Funabiki K, Horikoshi S, Shirato I, Tomino Y.

J Clin Lab Anal. 2002;16(1):1-4.

PMID:
11835523
14.

Association of the DD genotype and development of Japanese type 2 diabetic nephropathy.

Gohda T, Makita Y, Shike T, Kobayashi M, Funabiki K, Haneda M, Kikkawa R, Watanabe T, Baba T, Yoshida H, Tomino Y.

Clin Nephrol. 2001 Dec;56(6):475-80.

PMID:
11770799
15.

Animal models.

Shike T, Funabiki K, Tomino Y.

Contrib Nephrol. 2001;(134):9-15. Review. No abstract available.

PMID:
11665296
16.

Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model.

Shike T, Hirose S, Kobayashi M, Funabiki K, Shirai T, Tomino Y.

Diabetes. 2001 Aug;50(8):1943-8.

17.

Dilazep hydrochloride, an antiplatelet drug, inhibits lipopolysaccharide-induced mouse mesangial cell IL-6 secretion and proliferation.

Gohda T, Makita Y, Shike T, Funabiki K, Shirato I, Tomino Y.

Kidney Blood Press Res. 2001;24(1):33-8.

18.

Effect of calcium channel blockers, nifedipine and benidipine, on death of cultured mouse mesangi al cells.

Shike T, Tashiro K, Gohda T, Funabiki K, Shirato I, Tomino Y.

Kidney Blood Press Res. 2000;23(2):126-32.

19.

Effect of dilazep hydrochloride, an antiplatelet agent, on the proliferation of cultured mouse glomerular mesangial cells.

Gohda T, Makita Y, Shike T, Funabiki K, Horikoshi S, Shirato I, Tomino Y.

Nephron. 2000 Jan;84(1):90-1. No abstract available.

PMID:
10644919
20.

Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients.

Tomino Y, Makita Y, Shike T, Gohda T, Haneda M, Kikkawa R, Watanabe T, Baba T, Yoshida H.

Nephron. 1999 Jun;82(2):139-44.

PMID:
10364706
21.

Detection of cell death of cultured mouse mesangial cells induced by oxidized low-density lipoprotein.

Tashiro K, Makita Y, Shike T, Shirato I, Sato T, Cynshi O, Tomino Y.

Nephron. 1999;82(1):51-8.

PMID:
10224484
22.

O/W lipid emulsions for parenteral drug delivery. IV. Changes in the pharmacokinetics and pharmacodynamics of a highly lipophilic drug, menatetrenone.

Sakaeda T, Kakushi H, Shike T, Takano K, Harauchi T, Hirata M, Hirano K.

J Drug Target. 1998;6(3):183-9.

PMID:
9888304
23.

Dissociated expression of collagen type IV subchains in diabetic kidneys of KKAy mice.

Funabiki K, Makita Y, Yamamoto M, Shike T, Fukui M, Sumiyoshi Y, Tomino Y.

Nephron. 1998 Oct;80(2):208-13.

PMID:
9736822
24.

Inhibition of ileal Na+/bile acid cotransporter by S-8921 reduces serum cholesterol and prevents atherosclerosis in rabbits.

Higaki J, Hara S, Takasu N, Tonda K, Miyata K, Shike T, Nagata K, Mizui T.

Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1304-11.

PMID:
9714138
25.

Increase of urinary type IV collagen in normoalbuminuric patients with impaired glucose tolerance.

Takizawa H, Satoh T, Kurusu A, Hishiki T, Shike T, Gohda T, Maeda A, Makita Y, Suzuki S, Fukui M, Tomino Y.

Nephron. 1998 Aug;79(4):474-5. No abstract available.

PMID:
9689166
26.

Monoclonal antibody P-31 recognizes a novel intermediate filament-associated protein (p250) in rat podocytes.

Kurihara H, Sunagawa N, Kobayashi T, Kimura K, Takasu N, Shike T.

Am J Physiol. 1998 May;274(5):F986-97. doi: 10.1152/ajprenal.1998.274.5.F986.

PMID:
9612338
27.

Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells.

Hara S, Shike T, Takasu N, Mizui T.

Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1258-66.

PMID:
9261255
28.

[Sarcoidosis representing multiple splenic nodules in a patient with IgA nephropathy].

Nishiya H, Yoshida H, Tomonari H, Hikita M, Shike T, Takeda Y, Kikuchi T, Kuriyama S, Sakai O.

Nihon Jinzo Gakkai Shi. 1996 Jan;38(1):40-5. Review. Japanese.

PMID:
8855136
29.

Rhabdomyolysis associated with bacteremia due to Streptococcus viridans.

Asao K, Utsunomiya Y, Hirano K, Shike T, Imasawa T, Omura K, Tomonari H, Kawamura T, Kuriyama S, Sakai O.

Intern Med. 1995 Aug;34(8):785-9.

30.

[Bacterial intracavernous carotid aneurysm presented as massive epistaxis].

Shike T, Hoshino H, Takagi M, Inafuku T, Takagi Y.

Rinsho Shinkeigaku. 1995 May;35(5):531-6. Review. Japanese.

PMID:
7664524
31.

[A 54-year-old man with generalized muscle atrophy and oculomotor paresis].

Komiya T, Shike T, Mori H, Santo ML, Suda K, Kondo T, Mizuno Y.

No To Shinkei. 1994 Sep;46(9):895-904. Japanese.

PMID:
7999450
32.

Platelet aggregation inhibitors in a Bhutanese medicinal plant, shug chher.

Kagawa K, Tokura K, Uchida K, Kakushi H, Shike T, Kikuchi J, Nakai H, Dorji P, Subedi L.

Chem Pharm Bull (Tokyo). 1993 Sep;41(9):1604-7.

PMID:
8221975
33.

Platelet aggregation inhibitors from Populus sieboldii Miquel.

Kagawa K, Tokura K, Uchida K, Kakushi H, Shike T.

Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2191-2.

PMID:
1423779
34.

Platelet aggregation inhibitors and inotropic constituents in Pyrolae herba.

Kagawa K, Tokura K, Uchida K, Kakushi H, Shike T, Nakai H.

Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2083-7.

PMID:
1423762
35.

[Effect of (+)-S-145 calcium salt dihydrate, an orally active antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation].

Kakushi H, Shike T, Hayasaki Y, Arita H, Uchida K.

Nihon Yakurigaku Zasshi. 1991 Aug;98(2):113-20. Japanese.

PMID:
1916541
36.

[Effect of cefaclor on guinea pig platelet aggregation in vitro].

Kakushi H, Shike T, Hayasaki Y, Matsubara T, Uchida K, Honma Y, Kawasumi K, Takeuchi Y.

Nihon Yakurigaku Zasshi. 1990 Jun;95(6):335-46. Japanese.

PMID:
2379885
37.
38.

[Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation].

Kakushi H, Shike T, Uchida K.

Nihon Yakurigaku Zasshi. 1989 Mar;93(3):171-8. Japanese.

PMID:
2731807
39.

Effects of latamoxef on in vitro and ex vivo thromboxane A2 generation in human platelets.

Mihara S, Kakushi H, Shike T, Uchida K, Maruyama T, Okabayashi T, Inoue T, Shirai D, Takeda Y, Hara H.

Thromb Res. 1988 Jan 15;49(2):215-24.

PMID:
3129816
40.
41.
42.

Effect of sex hormones on hypoprothrombinemia induced by N-methyltetrazolethiol in rats.

Uchida K, Shike T, Kakushi H, Takase H, Nomura Y, Harauchi T, Yoshizaki T.

Thromb Res. 1985 Sep 15;39(6):741-50.

PMID:
4082108

Supplemental Content

Support Center